<div id="readability-page-1"><div><p>Health-care companies rose as traders sought out evergreen sectors in light of recent volatility.</p><p>    Shares of Eli Lilly rose, and the maker of Zepbound and other obesity drugs became the first pharmaceutical company to hit $1 trillion in market capitalization. </p><p>    British drugmaker GSK and U.S. biotechnology company AnaptysBio are suing one another, with dueling allegations about breaching a licensing agreement for cancer treatment Jemperli. </p><p>   Write to Rob Curran at rob.curran@dowjones.com </p><p>    (END) Dow Jones Newswires</p><p>11-21-25 1734ET</p></div></div>

礼来

葛兰素史克

<p>医疗保健公司因交易者在近期波动中寻求稳定的行业而上涨。礼来的股票上涨，该公司生产的 Zepbound 和其他肥胖药物使其成为首家市值达到 1 万亿美元的制药公司。英国制药公司葛兰素史克与美国生物技术公司 AnaptysBio 相互起诉，双方就癌症治疗药物 Jemperli 的许可协议违反问题展开激烈争论。请联系 Rob Curran，邮箱为 rob.curran@dowjones.com (完) 道琼斯新闻社 11-21-25 1734ET</p>

医疗保健板块上涨，因交易员寻求投资于常青行业——医疗保健综述